Looking back the 6 months plus since we head anything other than mandatory reporting from LCT the two main active programs should by rights be well in progress . Both ( Migraine and Obesity) say completion to license from Nov 19 to March 21. So already 6 months in. Maybe we will hear soon if they are progressing to plan / virus impact etc - have the 48 patients across both studies been selected for example. I assume the patent Auckland Uni ( professor Brimble) was working on during the lock down was/is Migraine related? An update from Ken Taylor on all his phone calls trying to get NT Cell off and running again would also be good. Something / anything to give us reassurance they are still a going concern would be a bonus.
Ann: CEO's presentation to AGM and market update, page-2
-
- There are more pages in this discussion • 67 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add 1AI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.81M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.7¢ | 0.7¢ | $4.495K | 642.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 4953269 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 954858 | 11 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| 1AI (ASX) Chart |